Poland· PL-100349219
Lixiana
A edoxaban product containing edoxabanum, registered in Poland by Daiichi Sankyo Europe GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Edoxaban is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Edoxaban · ATC B01AF03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of edoxaban costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Edoxaban · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$7.87
- CH Switzerland$6.81
The record
At a glance
URPL (Poland)- Active substance
- Edoxabanum
- Manufacturer
- Daiichi Sankyo Europe GmbH
- Country
- Poland (PL)
- ATC code
- B01AF03
- ATC class
- Edoxaban
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05901549325041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
262 interactions on record for edoxaban.
Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Edoxaban · interactions on record
262 records
- 182 severe
- 80 moderate
Most severe, free to view
- RolapitantA04AD14severe
- EliglustatA16AX10severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Edoxaban in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELIANDAKrka, d.d., Novo mesto, Novo mesto
- SwedenEdoflusio 15 mg Filmdragerad tablettSandoz A/S
- NetherlandsEdoxaban Cipla 15 mg, filmomhulde tablettenCipla Europe N.V.
- SpainEDOXABAN ALMUS 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAlmus Farmaceutica S.A.U.
- FinlandEdoxaban AvansorAvansor Pharma Oy
- IrelandEdoxaban Accord 15 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- IcelandEdoxaban AccordAccord Healthcare B.V.
- BelgiumEdoxaban HCS 15 mgHCS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Edoflusio, Edoxaban !@ctavis
- Belgium · Edoxaban Hcs, Edoxaban Sandoz
- Bulgaria · Edoflusio, Делианда
- Czechia · Delianda, Edoxaban +pharma
- Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
- Denmark · Arelzamio, Dijuga
- Estonia · Delianda, Edoflusio
- Spain · Edoxabán Almus, Edoxabán Cinfa
- Finland · Edoxaban Avansor, Edoxaban Krka
- France · Oblonela
- United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
- Greece · Delianda, Edoxaban Pharmapath
- Croatia · Cagluen, Delianda
- Hungary · Cagluen, Delianda
- Ireland · Edoxaban Accord, Edoxaban Krka
- Iceland · Edoxaban Accord, Edoxaban Krka
- Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
- Liechtenstein · Lixiana, Roteas
- Lithuania · Delianda, Edoflusio
- Luxembourg · Oblonela
- Latvia · Delianda, Edoflusio
- Malta · Arelzamio, Dijuga
- Netherlands · Edoxaban Cipla, Edoxaban G.L. Pharma
- Norway · Edoxaban Krka, Edoxaban Sandoz
- Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
- Romania · Cagluen, Delianda
- Sweden · Edoflusio, Edoxaban Avansor
- Slovenia · Delianda, Edoflusio
- Slovakia · Delianda, Edoxaban Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/adb9ad80-67f2-4b43-b40c-07c7535fd9e6 GET /v1/drugs/adb9ad80-67f2-4b43-b40c-07c7535fd9e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "15 mg",
"packaging": "05901549325041 ¦ Rp ¦ EU/1/15/993/001 ¦ 109609\n10 tabl.\nRp ¦ EU/1/15/993/016 ¦ 109610\n10 tabl. (10 x 1)",
"substance": "Edoxabanum 15 mg",
"common_name": "Edoxabanum",
"pl_product_id": "100349219",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about edoxaban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.